MZOR 10.94 Mazor Robotics Ltd $MZOR Hit a 52 week low of 10.60 Currently at 10.94 +0.01 +0.09% With a day low of 10.60 and a total volume of 46,600.
MZOR Mazor Robotics Ltd Recent Headline News
Mazor Robotics widens loss in Q3 2014
M2 - Thu Oct 30, 7:46AM CDT
Mazor Robotics Ltd. (TASE:MZOR)(NasdaqGM:MZOR), a developer of robotic, surgical guidance systems and complementary products, today reported a net loss of USD3.9m, or USD0.09 per share, for the third quarter of 2014, ended 30 September 2014.
MZOR: 10.94 (+0.01)
Mazor Robotics Announces Third Quarter and Nine Month Financial Results
Business Wire - Thu Oct 30, 3:30AM CDT
--- Recurring Quarterly Revenue Increased 67% Year-over-Year Reflecting Increased System Installed Base and Utilization
MZOR: 10.94 (+0.01)
Computer Assisted Surgical (CAS) Systems - 2014 Global Strategic Business Report
M2 - Tue Oct 28, 4:16AM CDT
Research and Markets (http://www.researchandmarkets.com/research/46xq77/computer_assisted) has announced the addition of the "Computer Assisted Surgical (CAS) Systems - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Computer Assisted Surgical (CAS) Systems in US$ by the following Product Segments: - Surgical Planners and Simulators - Surgical Navigation Systems - Surgical Robots The report profiles 56 companies including many key and niche players such as: - 3D Systems Corporation - Accuray, Inc. - B. Braun Melsungen AG - Brainlab AG - CAE, Inc. - CONMED Corporation - Curexo Technology Corporation - Hansen Medical, Inc. - Intuitive Surgical, Inc. - Medtronic, Inc. - Mazor Robotics Ltd. - Northern Digital Inc. - Polhemus, Inc. - Simbionix USA Corp. - Stryker Corporation Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Surgical Robots Market - A Review 3. An Insight Into Surgical Planners & Simulators Market 4. Surgical Navigation Systems Market 5. Product Overview 6. Cas In Select Medical Domains 7. Product Introductions/Innovations/ Approvals 8. Recent Industry Activity 9. Focus On Select Players 10. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Rest Of World IV. Competitive Landscape Total Companies Profiled: 56 (including Divisions/Subsidiaries - 57) - The United States (38) - Canada (3) - Japan (1) - Europe (14) - - France (1) - - Germany (6) - - The United Kingdom (2) - - Italy (1) - - Rest of Europe (4) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/46...r_assisted
ISRG: 500.02 (-8.63), MDT: 68.10 (-0.64), HNSN: 0.83 (-0.07), DDD: 34.47 (-0.44), CNMD: 41.77 (-0.23), MZOR: 10.94 (+0.01), ARAY: 6.85 (-0.05), SYK: 87.47 (-1.08)
Mazor Robotics to Report Third Quarter 2014 Financial Results on October 30, 2014
Business Wire - Tue Oct 21, 3:30AM CDT
Mazor Robotics Ltd. (TASE:MZOR; NASDAQGM:MZOR), a developer of innovative guidance systems and complementary products, announced today that it will report financial results for the third quarter ended September 30, 2014, before the U.S. markets open on Thursday, October 30, 2014.
MZOR: 10.94 (+0.01)
Mazor Robotics announces promotion of Christopher Prentice as CEO of US subsidiary
M2 - Tue Oct 14, 7:08AM CDT
Mazor Robotics Ltd (TASE:MZOR)(Nasdaq:MZOR), a developer of surgical guidance systems and complementary products, announced on Tuesday that it has promoted Christopher Prentice, SVP America & Global Marketing, to the position of CEO of Mazor Robotics Inc, the US subsidiary of the company.
MZOR: 10.94 (+0.01)
Mazor Robotics Ltd. Promotes Christopher Prentice to CEO of its US Subsidiary
Business Wire - Tue Oct 14, 3:00AM CDT
Mazor Robotics Ltd. (TASE:MZOR; NASDAQ GM:MZOR), a developer of innovative guidance systems and complementary products, announced today that Christopher Prentice, SVP America & Global Marketing, has been promoted to be the Chief Executive Officer of Mazor Robotics, Inc., the US subsidiary of Mazor Robotics Ltd. Mr. Prentice will report directly to Ori Hadomi, Chief Executive Officer of Mazor Robotics Ltd, the parent company of Mazor Robotics Inc.
MZOR: 10.94 (+0.01)
Mazor Robotics Ltd. (MZOR) in Focus: Stock Soars 11.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 07, 8:18AM CDT
Mazor Robotics Ltd. (MZOR) was a big mover last session, as the company saw its shares rise by over 11% on the day.
OPK: 8.32 (-0.10), MZOR: 10.94 (+0.01), ERB: 3.12 (+0.02)
4 Stocks Spiking on Unusual Volume
at The Street - Tue Oct 07, 6:00AM CDT
Often when above-average volume moves into an equity, it precedes a large spike in volatility.
BID: 39.44 (+0.34), BCR: 162.38 (-2.59), CLH: 48.74 (+2.18), MZOR: 10.94 (+0.01)
Globalstar Report Pits Soros Against Another Short
at The Street - Mon Oct 06, 11:50AM CDT
George Soros finds himself up against another short big with a new report calling Globalstar "worthless."Petroleo Brasileiro Petrobras SA (NYSE
BR), Mazor Robotics Ltd. (NASDAQ:MZOR) and Rio Tinto (N...
PBR: 10.90 (+0.17), END: 0.16 (-0.03), MZOR: 10.94 (+0.01), RIO: 48.37 (+1.25), GSAT: 2.62 (+0.14)
Mazor Robotics sells five Renaissance systems during Q3 2014
M2 - Mon Oct 06, 6:41AM CDT
Mazor Robotics Ltd (TASE:MZOR)(NasdaqGM:MZOR), a developer of surgical guidance systems and complementary products, announced today the sale of five Renaissance systems in the third quarter of 2014, ended 30 September 2014.
MZOR: 10.94 (+0.01)
Mazor Robotics Reports Sale of Five Renaissance Systems During the Third Quarter of 2014
Business Wire - Mon Oct 06, 3:30AM CDT
Mazor Robotics Ltd. (TASE:MZOR; NASDAQ GM:MZOR), a developer of innovative guidance systems and complementary products, announced today that it sold five Renaissance systems in the third quarter which ended September 30, 2014. One of the five systems sold was a Renaissance system that included both the Spine and Brain modules. Additionally the Company sold two brain module upgrades to existing Renaissance users. The Brain module was commercially launched in the second quarter of 2014. The Renaissance systems and the brain module upgrades sold in the quarter were all installed in the U.S. market.
MZOR: 10.94 (+0.01)
Mazor Robotics Co-Founder and CTO, Professor Moshe Shoham, joins new members honored at 50th annual NAE Meeting
GlobeNewswire - Tue Sep 30, 7:09AM CDT
Earlier this week, Mazor Robotics Co-Founder and Chief Technology Officer, Professor Moshe Shoham, was honored at the National Academy of Engineering (NAE) Annual Meeting in Washington, D.C. All new members were recognized as they celebrated the organization's 50 anniversary. This past February, Prof. Shoham was elected into the National Academy of Engineering (NAE) for contributions to robotic technology for image-guided surgery.
MZOR: 10.94 (+0.01)
Mazor Robotics announces China Food and Drug Administration approval in China for Renaissance surgical guidance system
M2 - Wed Sep 10, 4:41AM CDT
Mazor Robotics Ltd (TASE: MZOR)(NasdaqGM: MZOR), a developer of surgical guidance systems and complementary products, announced on Tuesday the approval by the China Food and Drug Administration (CFDA) of its Renaissance system, a state-of-the-art surgical guidance system that enables surgeons to accurately and securely conduct spine surgery.
MZOR: 10.94 (+0.01)
Mazor Robotics Receives China CFDA Approval for Its Renaissance Systems
Business Wire - Tue Sep 09, 4:14AM CDT
Mazor Robotics Ltd. (TASE: MZOR; NASDAQ GM: MZOR), a developer of innovative guidance systems and complementary products, announced today that the China Food and Drug Administration (CFDA) has approved the Company's Renaissance(R) system, a state-of-the-art surgical guidance system that enables surgeons to conduct spine surgeries in an accurate and secure manner.
MZOR: 10.94 (+0.01)
Mazor Robotics Receives China Cfda Approval for Its Renaissance Systems
Business Wire - Tue Sep 09, 3:30AM CDT
Mazor Robotics Ltd. (TASE: MZOR; NASDAQ GM: MZOR), a developer of innovative guidance systems and complementary products, announced today that the China Food and Drug Administration (CFDA) has approved the Company's Renaissance(R) system, a state-of-the-art surgical guidance system that enables surgeons to conduct spine surgeries in an accurate and secure manner.
MZOR: 10.94 (+0.01)
Mazor Robotics (MZOR) Jumps: Stock Moves 6.6% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Sep 04, 8:25AM CDT
Mazor Robotics (MZOR) was a big mover last session, with shares rising nearly 7% on the day.
ECTE: 0.67 (unch), BONE: 4.07 (-0.08), RTIX: 5.09 (+0.02), MZOR: 10.94 (+0.01)
3 Stocks Spiking on Big Volume
at The Street - Thu Sep 04, 5:00AM CDT
Often when above-average volume moves into an equity, it precedes a large spike in volatility.
VIPS: 23.34 (-0.04), MZOR: 10.94 (+0.01), CORE: 58.04 (+1.59)
Study Finds Improved Accuracy and Safety Utilizing Mazor Robotics Renaissance Guidance System
Business Wire - Thu Aug 21, 7:00AM CDT
Utilization of Mazor Robotics (TASE:MZOR) (NASDAQCM:MZOR) Renaissance(R) Guidance System provides greater reliability in screw placement and reduced use of fluoroscopy, according to a prospective study published in the current issue of Turkish Neurosurgery.(1)
MZOR: 10.94 (+0.01)
Mazor Robotics Announces Second Quarter and Six Months 2014 Financial Results
Business Wire - Tue Aug 05, 3:30AM CDT
--- Recurring Quarterly Revenue Increases 17% Year-over-Year Reflecting Increased System Installed Base and Utilization -
MZOR: 10.94 (+0.01)
Mazor Robotics to Report Second Quarter 2014 Financial Results on August 5, 2014
Business Wire - Mon Jul 28, 3:30AM CDT
Mazor Robotics Ltd. (TASE:MZOR; NASDAQGM:MZOR), a developer of innovative guidance systems and complementary products, announced today that it will report financial results for the second quarter ended June 30, 2014, before the U.S. markets open on Tuesday, August 5, 2014.
MZOR: 10.94 (+0.01)
MZOR Mazor Robotics Ltd Recent Headline News
Mazor Robotics widens loss in Q3 2014
M2 - Thu Oct 30, 7:46AM CDT
Mazor Robotics Ltd. (TASE:MZOR)(NasdaqGM:MZOR), a developer of robotic, surgical guidance systems and complementary products, today reported a net loss of USD3.9m, or USD0.09 per share, for the third quarter of 2014, ended 30 September 2014.
MZOR: 10.94 (+0.01)
Mazor Robotics Announces Third Quarter and Nine Month Financial Results
Business Wire - Thu Oct 30, 3:30AM CDT
--- Recurring Quarterly Revenue Increased 67% Year-over-Year Reflecting Increased System Installed Base and Utilization
MZOR: 10.94 (+0.01)
Computer Assisted Surgical (CAS) Systems - 2014 Global Strategic Business Report
M2 - Tue Oct 28, 4:16AM CDT
Research and Markets (http://www.researchandmarkets.com/research/46xq77/computer_assisted) has announced the addition of the "Computer Assisted Surgical (CAS) Systems - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Computer Assisted Surgical (CAS) Systems in US$ by the following Product Segments: - Surgical Planners and Simulators - Surgical Navigation Systems - Surgical Robots The report profiles 56 companies including many key and niche players such as: - 3D Systems Corporation - Accuray, Inc. - B. Braun Melsungen AG - Brainlab AG - CAE, Inc. - CONMED Corporation - Curexo Technology Corporation - Hansen Medical, Inc. - Intuitive Surgical, Inc. - Medtronic, Inc. - Mazor Robotics Ltd. - Northern Digital Inc. - Polhemus, Inc. - Simbionix USA Corp. - Stryker Corporation Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Surgical Robots Market - A Review 3. An Insight Into Surgical Planners & Simulators Market 4. Surgical Navigation Systems Market 5. Product Overview 6. Cas In Select Medical Domains 7. Product Introductions/Innovations/ Approvals 8. Recent Industry Activity 9. Focus On Select Players 10. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Rest Of World IV. Competitive Landscape Total Companies Profiled: 56 (including Divisions/Subsidiaries - 57) - The United States (38) - Canada (3) - Japan (1) - Europe (14) - - France (1) - - Germany (6) - - The United Kingdom (2) - - Italy (1) - - Rest of Europe (4) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/46...r_assisted
ISRG: 500.02 (-8.63), MDT: 68.10 (-0.64), HNSN: 0.83 (-0.07), DDD: 34.47 (-0.44), CNMD: 41.77 (-0.23), MZOR: 10.94 (+0.01), ARAY: 6.85 (-0.05), SYK: 87.47 (-1.08)
Mazor Robotics to Report Third Quarter 2014 Financial Results on October 30, 2014
Business Wire - Tue Oct 21, 3:30AM CDT
Mazor Robotics Ltd. (TASE:MZOR; NASDAQGM:MZOR), a developer of innovative guidance systems and complementary products, announced today that it will report financial results for the third quarter ended September 30, 2014, before the U.S. markets open on Thursday, October 30, 2014.
MZOR: 10.94 (+0.01)
Mazor Robotics announces promotion of Christopher Prentice as CEO of US subsidiary
M2 - Tue Oct 14, 7:08AM CDT
Mazor Robotics Ltd (TASE:MZOR)(Nasdaq:MZOR), a developer of surgical guidance systems and complementary products, announced on Tuesday that it has promoted Christopher Prentice, SVP America & Global Marketing, to the position of CEO of Mazor Robotics Inc, the US subsidiary of the company.
MZOR: 10.94 (+0.01)
Mazor Robotics Ltd. Promotes Christopher Prentice to CEO of its US Subsidiary
Business Wire - Tue Oct 14, 3:00AM CDT
Mazor Robotics Ltd. (TASE:MZOR; NASDAQ GM:MZOR), a developer of innovative guidance systems and complementary products, announced today that Christopher Prentice, SVP America & Global Marketing, has been promoted to be the Chief Executive Officer of Mazor Robotics, Inc., the US subsidiary of Mazor Robotics Ltd. Mr. Prentice will report directly to Ori Hadomi, Chief Executive Officer of Mazor Robotics Ltd, the parent company of Mazor Robotics Inc.
MZOR: 10.94 (+0.01)
Mazor Robotics Ltd. (MZOR) in Focus: Stock Soars 11.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 07, 8:18AM CDT
Mazor Robotics Ltd. (MZOR) was a big mover last session, as the company saw its shares rise by over 11% on the day.
OPK: 8.32 (-0.10), MZOR: 10.94 (+0.01), ERB: 3.12 (+0.02)
4 Stocks Spiking on Unusual Volume
at The Street - Tue Oct 07, 6:00AM CDT
Often when above-average volume moves into an equity, it precedes a large spike in volatility.
BID: 39.44 (+0.34), BCR: 162.38 (-2.59), CLH: 48.74 (+2.18), MZOR: 10.94 (+0.01)
Globalstar Report Pits Soros Against Another Short
at The Street - Mon Oct 06, 11:50AM CDT
George Soros finds himself up against another short big with a new report calling Globalstar "worthless."Petroleo Brasileiro Petrobras SA (NYSE
BR), Mazor Robotics Ltd. (NASDAQ:MZOR) and Rio Tinto (N... PBR: 10.90 (+0.17), END: 0.16 (-0.03), MZOR: 10.94 (+0.01), RIO: 48.37 (+1.25), GSAT: 2.62 (+0.14)
Mazor Robotics sells five Renaissance systems during Q3 2014
M2 - Mon Oct 06, 6:41AM CDT
Mazor Robotics Ltd (TASE:MZOR)(NasdaqGM:MZOR), a developer of surgical guidance systems and complementary products, announced today the sale of five Renaissance systems in the third quarter of 2014, ended 30 September 2014.
MZOR: 10.94 (+0.01)
Mazor Robotics Reports Sale of Five Renaissance Systems During the Third Quarter of 2014
Business Wire - Mon Oct 06, 3:30AM CDT
Mazor Robotics Ltd. (TASE:MZOR; NASDAQ GM:MZOR), a developer of innovative guidance systems and complementary products, announced today that it sold five Renaissance systems in the third quarter which ended September 30, 2014. One of the five systems sold was a Renaissance system that included both the Spine and Brain modules. Additionally the Company sold two brain module upgrades to existing Renaissance users. The Brain module was commercially launched in the second quarter of 2014. The Renaissance systems and the brain module upgrades sold in the quarter were all installed in the U.S. market.
MZOR: 10.94 (+0.01)
Mazor Robotics Co-Founder and CTO, Professor Moshe Shoham, joins new members honored at 50th annual NAE Meeting
GlobeNewswire - Tue Sep 30, 7:09AM CDT
Earlier this week, Mazor Robotics Co-Founder and Chief Technology Officer, Professor Moshe Shoham, was honored at the National Academy of Engineering (NAE) Annual Meeting in Washington, D.C. All new members were recognized as they celebrated the organization's 50 anniversary. This past February, Prof. Shoham was elected into the National Academy of Engineering (NAE) for contributions to robotic technology for image-guided surgery.
MZOR: 10.94 (+0.01)
Mazor Robotics announces China Food and Drug Administration approval in China for Renaissance surgical guidance system
M2 - Wed Sep 10, 4:41AM CDT
Mazor Robotics Ltd (TASE: MZOR)(NasdaqGM: MZOR), a developer of surgical guidance systems and complementary products, announced on Tuesday the approval by the China Food and Drug Administration (CFDA) of its Renaissance system, a state-of-the-art surgical guidance system that enables surgeons to accurately and securely conduct spine surgery.
MZOR: 10.94 (+0.01)
Mazor Robotics Receives China CFDA Approval for Its Renaissance Systems
Business Wire - Tue Sep 09, 4:14AM CDT
Mazor Robotics Ltd. (TASE: MZOR; NASDAQ GM: MZOR), a developer of innovative guidance systems and complementary products, announced today that the China Food and Drug Administration (CFDA) has approved the Company's Renaissance(R) system, a state-of-the-art surgical guidance system that enables surgeons to conduct spine surgeries in an accurate and secure manner.
MZOR: 10.94 (+0.01)
Mazor Robotics Receives China Cfda Approval for Its Renaissance Systems
Business Wire - Tue Sep 09, 3:30AM CDT
Mazor Robotics Ltd. (TASE: MZOR; NASDAQ GM: MZOR), a developer of innovative guidance systems and complementary products, announced today that the China Food and Drug Administration (CFDA) has approved the Company's Renaissance(R) system, a state-of-the-art surgical guidance system that enables surgeons to conduct spine surgeries in an accurate and secure manner.
MZOR: 10.94 (+0.01)
Mazor Robotics (MZOR) Jumps: Stock Moves 6.6% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Sep 04, 8:25AM CDT
Mazor Robotics (MZOR) was a big mover last session, with shares rising nearly 7% on the day.
ECTE: 0.67 (unch), BONE: 4.07 (-0.08), RTIX: 5.09 (+0.02), MZOR: 10.94 (+0.01)
3 Stocks Spiking on Big Volume
at The Street - Thu Sep 04, 5:00AM CDT
Often when above-average volume moves into an equity, it precedes a large spike in volatility.
VIPS: 23.34 (-0.04), MZOR: 10.94 (+0.01), CORE: 58.04 (+1.59)
Study Finds Improved Accuracy and Safety Utilizing Mazor Robotics Renaissance Guidance System
Business Wire - Thu Aug 21, 7:00AM CDT
Utilization of Mazor Robotics (TASE:MZOR) (NASDAQCM:MZOR) Renaissance(R) Guidance System provides greater reliability in screw placement and reduced use of fluoroscopy, according to a prospective study published in the current issue of Turkish Neurosurgery.(1)
MZOR: 10.94 (+0.01)
Mazor Robotics Announces Second Quarter and Six Months 2014 Financial Results
Business Wire - Tue Aug 05, 3:30AM CDT
--- Recurring Quarterly Revenue Increases 17% Year-over-Year Reflecting Increased System Installed Base and Utilization -
MZOR: 10.94 (+0.01)
Mazor Robotics to Report Second Quarter 2014 Financial Results on August 5, 2014
Business Wire - Mon Jul 28, 3:30AM CDT
Mazor Robotics Ltd. (TASE:MZOR; NASDAQGM:MZOR), a developer of innovative guidance systems and complementary products, announced today that it will report financial results for the second quarter ended June 30, 2014, before the U.S. markets open on Tuesday, August 5, 2014.
MZOR: 10.94 (+0.01)
